🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
SLN
$SLN
🔒 US EquitiesSilence Therapeutics Plc
AVG HISTORICAL GAP
-1.31%
MAX GAP RECORD
-6.57%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $SLN
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$SLN
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 10, 2026 Earnings Release 2026-08-10 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (UNDETERMINED) |
+0.00%
|
| Mar 05, 2026 Earnings Release 2026-03-05 (BEFORE OPEN) |
-6.57%
|
| Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE) |
-1.09%
|
| Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE) |
-2.42%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
-1.35%
|
| Nov 14, 2024 Earnings Release 2024-11-14 (UNDETERMINED) |
+0.00%
|
| Aug 14, 2024 Earnings Release 2024-08-14 (UNDETERMINED) |
+0.00%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.5%
Bullish Gaps (2)
Bearish Gaps (4)
Neutral / Flat (0)
📖 Intelligence Summary
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗